In this week’s Video Forum, Joe DePinto, head of cell, gene and advanced therapies at McKesson, talks about the company’s new InspiroGene division and the impact it is expected to have on the biotech marketplace. Precision dispensing and patient management, the product pipeline for advanced therapies, and recent research from InspiroGene were among the topics discussed.
Video Forum: Joe DePinto, McKesson
New division takes aim at cell and gene therapies.
Related
Video Forum: Nicholas Hall, Nicholas Hall Group of Companies, Part 2
Self-care to play bigger part in treatment and prevention.
Video Forum: Nicholas Hall, Nicholas Hall Group of Companies, Part 1
Charting the trajectory of self-care.
Latest
Walmart launches Better Care Services and lowers prices on wellness essentials
Better Care Services connects customers to a network of third-party providers for urgent care and behavioral health.
Deloitte’s 2026 Retail Outlook: Five forces impacting the industry
Nearly all respondents expect rising costs due to trade policies.
Retail job cuts surge to post-2020 high
Retail’s decline reflected broader labor market stress.
CHPA backs new dietary guidelines
CHPA appreciates the ongoing recognition that dietary supplements support individuals in meeting nutrient needs when diet alone falls short.